On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of Plasmodium vivax (P. vivax) infection.
In RFK Jr.’s promise to go after ‘big food,’ some public health officials see a silver lining
In their long slog to tame the big food lobby, Jerold Mande often had to assure his allies that the time would come when the
December 3, 2024